Maxona Pharmaceuticals has received U.S. FDA clearance of its Investigational New Drug application for a Phase 2 clinica...
The pharmaceutical industry’s innovation equation is changing. Developing an entirely new molecu...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Lynk Pharmaceuticals has completed patient enrolment in its Phase III clinical trial of zemprocitinib capsules for activ...
Lynk Pharmaceuticals has dosed the first patient in a Phase II clinical trial of LNK01004 ointment for vitiligo. The tr...
China-based startup OTR Therapeutics has entered into a strategic collaboration agreement with Korean company LG Chem to...
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administrati...
BioMed X, a leading innovation engine for pharma, and Boehringer Ingelheim have announced the launch of a new research t...
Insilico Medicine has initiated a Phase III clinical trial of rentosertib, its AI-discovered oral small-molecule TNIK in...
Evogene, a leading computational chemistry company focused on the generative design of small molecules for the pharmaceu...
REPROCELL has submitted an application for manufacturing and marketing approval in Japan for Stemchymal, a regenerative ...
Brii Biosciences has reported topline end-of-treatment data from its ongoing Phase 2b ENRICH and ENHANCE studies evaluat...
Ascletis Pharma has submitted two Investigational New Drug applications to the U.S. FDA for obesity treatment candidates...
Viking Therapeutics has initiated a Phase 1 clinical study of VK3019, an investigational dual amylin and calcitonin rece...
Hong Kong-based Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, has announced a strategi...
NeuroSense Therapeutics has reported positive biomarker findings from its Phase 2 RoAD proof-of-concept study of PrimeC ...
Innovative Molecules has dosed the first patient in its Phase 2a clinical trial evaluating adibelivir for recurrent geni...
Servier has enrolled the first U.S. patient in a Phase Ib/II first-in-human clinical study evaluating an investigational...
CeleCor Therapeutics has completed submission of its New Drug Application to the U.S. FDA for zalunfiban, its investigat...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Lan Nguyen, Ch...
While most cardiovascular research has traditionally focused on the heart and large blood vessels, a growing body of evi...
As the pharmaceutical industry advances towards increasingly complex, poorly soluble drug candidates, formulation has ...
NVIDIA announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life scie...
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with U.S.-based biotechnology company Nuve...
